1d agoThe FlyBULLISH 56General
Archived explainer. For the current picture see today's PLSE page.
Why Is PULSE BIOSCIENCES IN (PLSE) Stock Up Today?
By the Top Tier Newswire AI Desk · August 11, 2026 at 2:50 PM ET · reviewed against 4 wire stories
PULSE BIOSCIENCES IN (PLSE) is up +7.53% in the latest session. Our newswire has captured 4 stories on PLSE across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 62/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why PLSE stock is up today
PLSE stock rose 7.53% to $44.63 on Friday, driven by a series of analyst upgrades and positive developments in the company’s clinical trials. The stock opened at $41.69 and climbed steadily throughout the session, reaching a high of $44.63 at 2:45 PM ET. The move reflects renewed investor optimism following multiple price target increases and a virtual meeting with institutional investors.
What Happened
Pulse Biosciences announced that its management will meet virtually with BTIG, signaling engagement with key institutional stakeholders. This comes alongside a series of analyst actions. Mizuho raised its price target for PLSE to $45 from $30, while Canaccord increased its target to $43 from $32. Additionally, Canaccord reiterated a Buy rating and raised its target to $43. These upgrades were based on clinical progress in the company’s NANOPULSE-AF atrial fibrillation study, which has surpassed the enrollment midpoint since its start in April 2026. The company is scheduled to provide an update on August 6 during its earnings call.
What The Data Shows
PLSE traded at 1.1 times its 3-month average volume, with 0.4 million shares changing hands. The stock is currently within its 52-week range of $12.56 to $45.90, near its 52-week high. Despite the recent rally, the company remains unprofitable, with a trailing twelve-month EPS of -1.18. The stock has a market cap of $2.6 billion and a beta of 1.58, indicating higher volatility compared to the broader market.
What To Watch
Investors should keep an eye on the August 6 earnings call for further updates on the NANOPULSE-AF study and other clinical developments. This event could provide additional clarity on the company’s growth trajectory and potential for future analyst action.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
PLSE by the numbers
Last: $44.63Session: +7.53%Coverage: 4 stories / 2 sourcesAI sentiment: 62/100 (bullish)Mkt cap: $2.6B52w: $12.56 to $45.90
The headlines behind the move
1d agoInvesting.com Analyst RatingsBULLISH 61Analyst
Canaccord raises Pulse Biosciences stock price target on clinical progress
Canaccord raises Pulse Biosciences stock price target on clinical progress
1d agoThe FlyBULLISH 63Analyst
Pulse Biosciences price target raised to $45 from $30 at Mizuho
1d agoThe FlyBULLISH 67Analyst
Pulse Biosciences price target raised to $43 from $32 at Canaccord
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on PLSE: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier PLSE move explainers: 2026-08-11 · 2026-08-07 · 2026-07-29 · 2026-07-28 · 2026-07-23 · 2026-07-22